[Effects of amrinone administered orally and by injection in heart failure].

Abstract

Amrinone is a new positive inotropic agent available in oral and intravenous preparations. Twelve patients with Stage III cardiac failure of ischaemic (6 cases), myocardial (5 cases) or valvular (1 case) origin, were treated with oral amrinone. The protocol included a complete clinical, radiological and biochemical work-up, an exercise stress test, cardiac… (More)

Topics

Cite this paper

@article{Bounhoure1985EffectsOA, title={[Effects of amrinone administered orally and by injection in heart failure].}, author={Jean-paul Bounhoure and Pierre Massabuau and J. -L. Puel and Joaqu{\'i}n Miquel and J Calazel}, journal={Annales de medecine interne}, year={1985}, volume={136 3}, pages={251-5} }